TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›CAMT
CAMT logo

CAMT

CAMTEK LTD

Next earnings Aug 3, 2026 · consensus $0.77 EPS, $133M rev

Hold
$142.50
▼ -9.42%
$142.50▲ +68.72%
over 1Y
L $76.73H $207.46
Today-9.4%
1W-15.2%
1M-24.0%
3M-9.7%
YTD+23.4%
1Y+68.7%
OverviewFinancialsValuationQualityFilings
Rating
Hold
Quality
C
Valuation
Overvalued
Hold
Conviction
Horizon
Long (>12mo)
Street · 18 analysts
Buy

Fast-growing chip-inspection equipment maker riding AI/advanced-packaging demand, but priced for perfection at 18x sales.

Revenue $496M · FY2025

The read

Middling fundamentals and a rich price (~94% above fair value) leave little margin of safety — a wait-and-see.

Camtek is a semiconductor metrology and inspection equipment supplier benefiting directly from the advanced-packaging and AI-chip build-out. The operating fundamentals are excellent: FY2025 revenue grew 15.6% to $496M, gross margin held at a robust 50.5%, and operating income grew 18.6% to $128M (a 25.8% operating margin). The multi-year trajectory is strong — revenue has nearly doubled from $270M (FY2021) — driven by demand for inspection tools used in high-bandwidth-memory and advanced packaging for AI accelerators. Operating cash flow grew 16.1% to $142M on minimal capex ($14.4M), and the balance sheet remains solid with $178M cash, current assets ($897M) dwarfing current liabilities ($107M).

The headline that demands caution is the apparent collapse in net income — down 57.2% to $50.7M and diluted EPS down 57.0% to $1.04 — even as revenue and operating income grew strongly. This divergence almost certainly reflects a non-operating item: FY2024 net income of $119M was well above operating income that year, suggesting a one-time gain or tax benefit inflated the prior-year base, while FY2025 net income includes financing-related costs (total liabilities jumped 87.5%, consistent with a convertible/debt raise). The reported P/E of 187.7x is therefore distorted by depressed GAAP earnings; on operating income the business is far more reasonably profitable, but ROE of 8.2% is modest.

Is CAMT a buy? The one-page verdict, explained →

The options angle

model · matches our verdict
Covered call~90d expiry
  • Long 100 shares @ ~142.50
  • Short call 150 @ ~25.68 est
debit $11,682max +$3,318max −$11,681BE 116.82

HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.

Open in the calculator →

Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$270M$321M$315M$429M$496M
Gross profit$137M$160M$148M$210M$250M
Operating income$70.9M$81.5M$65.4M$108M$128M
Net income$60.3M$79.9M$78.6M$119M$50.7M
Diluted EPS$1.34$1.68$1.63$2.42$1.04
Net margin22.4%24.9%24.9%27.6%10.2%

10-year statements — income, cash flow, balance sheet & CSV export →

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$6.47B
EV / EBITDA46.3
EV / Sales13.1
EV / FCF50.8
P / FCF52.2
PEG (trailing)—
Earnings yield0.8%
FCF yield1.9%

Quality & risk

ROIC (est.)16.3%
Free cash flow$127M
Total debt$3.79M
Net cash$174M
Altman Z-Score8.12 safe
Piotroski F-Score5/8

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+0.8%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Recent filings

all on EDGAR ↗
6-KPeriod ending 2026-06-242026-06-24open ↗6-KPeriod ending 2026-06-242026-06-24open ↗S-8Filing2026-06-17open ↗6-KPeriod ending 2026-06-022026-06-02open ↗SDFiling2026-05-26open ↗6-KPeriod ending 2026-05-122026-05-12open ↗SCHEDULE 13G/AFiling2026-05-05open ↗SCHEDULE 13G/AFiling2026-04-22open ↗6-KPeriod ending 2026-04-142026-04-14open ↗3Period ending 2026-04-132026-04-13open ↗3Period ending 2026-04-132026-04-13open ↗3Period ending 2026-04-132026-04-13open ↗

Quality score

C
ValueGrowthProfitHealthMom.
ValueF
GrowthD
ProfitabilityB+
Financial healthB+
MomentumD
  • ✓Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✓Net margin above 10%
  • ✗Return on equity above 15%
  • ✓Liabilities below 2× equity
  • ✗P/E below 25

Fair value est.

$8.84

Overvalued -94% vs price

cheapfair valueexpensive

Modified Graham: EPS $1.04 × (8.5 + 1.5 × 0.0% growth) × 1.00 quality = 8.5× multiple. An estimate, not a price target.

76.7352-week207.46
Revenue
$496M
+15.6% YoY
Net margin
10.2%
ROE
8.2%
P/E
137.0

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$496M+15.6%
Net income$50.7M-57.2%
Gross profit$250M+19.2%
Operating income$128M+18.6%
Diluted EPS$1.04-57.0%
Cash & equivalents$178M+40.9%
Total assets$1.26B+41.2%
Total liabilities$643M+87.5%
Stockholders' equity$617M+12.3%
Gross: 50.5%Op.: 25.8%L/E: 1.04x

Frequently asked

Is CAMTEK LTD (CAMT) a buy?
CAMT currently carries a Hold rating with 2/5 conviction, derived from its latest SEC filings. Fast-growing chip-inspection equipment maker riding AI/advanced-packaging demand, but priced for perfection at 18x sales.
What is CAMT's fair value?
A Modified-Graham model based on CAMT's SEC fundamentals estimates a fair value of about $8.84. It is an estimate from reported earnings, not a price target.
Is CAMT overvalued or undervalued?
Against a Modified-Graham fair-value estimate, CAMT currently appears overvalued relative to its SEC-grounded earnings power.
What is CAMTEK LTD's quality score?
CAMT scores 56.60281873138242/100 (grade C) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001109138, latest 6-K filed 2026-06-24) · EODHD · Proprietary analysis · as of 6/21/2026, 8:51:14 PM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 4:51 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Held by tracked funds

Form 13F · SEC · quarterly
ARK Investment ManagementCathie Wood15.4K sh$2.33M

As of each fund’s latest quarterly 13F — a delayed snapshot, not a live position. All tracked funds →

Recent news

market news →
Camtek (CAMT) Stock Moves -8.35%: What You Should KnowBullish
finance.yahoo.com· 2026-07-02
ONTO Stock Climbs 26% in a Month: What's the Next Move for Investors?Bullish
finance.yahoo.com· 2026-07-02
Camtek (CAMT) Soars 3.7%: Is Further Upside Left in the Stock?Bullish
finance.yahoo.com· 2026-07-01
Camtek (CAMT) Sees a More Significant Dip Than Broader Market: Some Facts to KnowBullish
finance.yahoo.com· 2026-06-26
Camtek (CAMT) Declines More Than Market: Some Information for InvestorsBullish
finance.yahoo.com· 2026-06-23
Camtek Reaches Analyst Target PriceBullish
nasdaq.com· 2026-06-22

Vs tracked universe

compare →

1195 tracked peers · median

TENK Score57 vs 67
Revenue growth15.6% vs 7.5%
Net margin10.2% vs 10.0%
Return on equity8.2% vs 12.0%
P/E137.0 vs 26.2